Charles River Laboratories International, Inc.
CRL
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 11 days ago • CRL
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
PRNewsWire • 12 days ago • CRL
Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
Zacks Investment Research • 18 days ago • CRL
Here's Why Charles River Laboratories (CRL) is a Great Momentum Stock to Buy
Reuters • 20 days ago • CRL
Charles River to buy Cambodia-based monkey supplier for $510 million
Business Wire • 20 days ago • CRL
Charles River Laboratories Provides Business Updates
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.